JPH0366606A - Hair tonic of compound crude drug - Google Patents
Hair tonic of compound crude drugInfo
- Publication number
- JPH0366606A JPH0366606A JP1202128A JP20212889A JPH0366606A JP H0366606 A JPH0366606 A JP H0366606A JP 1202128 A JP1202128 A JP 1202128A JP 20212889 A JP20212889 A JP 20212889A JP H0366606 A JPH0366606 A JP H0366606A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- radix
- hair growth
- crude drug
- alopecia areata
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 229940079593 drug Drugs 0.000 title claims abstract description 24
- 210000004209 hair Anatomy 0.000 title abstract description 22
- 230000001256 tonic effect Effects 0.000 title abstract description 6
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000003779 hair growth Effects 0.000 claims abstract description 43
- 241000208340 Araliaceae Species 0.000 claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 239000000126 substance Substances 0.000 claims abstract description 5
- 241000411851 herbal medicine Species 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 21
- 239000002131 composite material Substances 0.000 claims description 12
- 241001061264 Astragalus Species 0.000 claims description 10
- 244000020518 Carthamus tinctorius Species 0.000 claims description 10
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 10
- 235000006533 astragalus Nutrition 0.000 claims description 10
- 210000004233 talus Anatomy 0.000 claims description 10
- 210000000988 bone and bone Anatomy 0.000 claims description 8
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 claims description 6
- 244000132619 red sage Species 0.000 claims description 6
- 244000144730 Amygdalus persica Species 0.000 claims description 4
- 235000002566 Capsicum Nutrition 0.000 claims description 4
- 239000006002 Pepper Substances 0.000 claims description 4
- 235000016761 Piper aduncum Nutrition 0.000 claims description 4
- 235000017804 Piper guineense Nutrition 0.000 claims description 4
- 235000008184 Piper nigrum Nutrition 0.000 claims description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 4
- 239000010396 fuzi Substances 0.000 claims description 4
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 239000012675 alcoholic extract Substances 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 241000722363 Piper Species 0.000 claims 3
- 235000019197 fats Nutrition 0.000 claims 3
- 208000004631 alopecia areata Diseases 0.000 abstract description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 18
- 235000019441 ethanol Nutrition 0.000 abstract description 13
- 230000035790 physiological processes and functions Effects 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 239000000284 extract Substances 0.000 abstract description 3
- 241000628997 Flos Species 0.000 abstract 2
- 239000008609 bushi Substances 0.000 abstract 2
- 210000000582 semen Anatomy 0.000 abstract 2
- 230000003450 growing effect Effects 0.000 abstract 1
- 230000000050 nutritive effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 31
- 230000004044 response Effects 0.000 description 15
- 230000017531 blood circulation Effects 0.000 description 14
- 201000004384 Alopecia Diseases 0.000 description 10
- 208000024963 hair loss Diseases 0.000 description 9
- 230000003676 hair loss Effects 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 230000007721 medicinal effect Effects 0.000 description 6
- 238000002054 transplantation Methods 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 235000003715 nutritional status Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000008338 local blood flow Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 108010087765 Antipain Proteins 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000131283 Cantharis Species 0.000 description 1
- 208000035357 Focal Infection Diseases 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- HEYZWPRKKUGDCR-QBXMEVCASA-N Swertiamarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)[C@]2(O)CCOC(=O)C2=CO1 HEYZWPRKKUGDCR-QBXMEVCASA-N 0.000 description 1
- HEYZWPRKKUGDCR-WRMJXEAJSA-N Swertiamarin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1[C@@H](C=C)[C@@]2(O)C(C(=O)OCC2)=CO1 HEYZWPRKKUGDCR-WRMJXEAJSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 206010044625 Trichorrhexis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047631 Vitamin E deficiency Diseases 0.000 description 1
- 206010047627 Vitamin deficiencies Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000009285 allergic inflammation Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- SDNYTAYICBFYFH-TUFLPTIASA-N antipain Chemical compound NC(N)=NCCC[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SDNYTAYICBFYFH-TUFLPTIASA-N 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000010454 developmental mechanism Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000000321 herbal drug Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000009707 neogenesis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野〕
本発明は複合生薬育毛剤に係わり、詳しくは円形脱毛症
に対して、皮膚生理機能の先進を促し、局所の血液循環
を促進し、皮膚に栄養と温潤作用を与える結果、発毛を
促す薬効を有する複合生薬育毛剤に関する。Detailed Description of the Invention (Industrial Field of Application) The present invention relates to a complex herbal hair growth agent, specifically for alopecia areata, which promotes the advancement of skin physiological functions, promotes local blood circulation, and improves skin growth. This invention relates to a complex herbal medicine hair growth agent that has the medicinal effect of promoting hair growth by imparting nourishing and moisturizing effects to hair.
〔従来の技術及び発明が解決しようとする課題〕円形脱
毛症の要因については、多くの学説が唱えられている。[Prior art and problems to be solved by the invention] Many theories have been proposed regarding the causes of alopecia areata.
古くは、ウィルス説、病巣感染説、神経障害説、内分秘
説、精神的ストレス説などが有力であったが、最近では
、遺伝的要因説や自己免疫説などが支持される傾向にあ
る。In the past, theories such as the virus theory, focal infection theory, neurological disorder theory, internal secretion theory, and mental stress theory were popular, but recently, theories such as genetic factors and autoimmunity have been gaining support. .
しかしながら、未だ円形脱毛症の要因について決定的な
定説をみるには到っていない。However, a definitive theory regarding the causes of alopecia areata has not yet been established.
従来、円形脱毛症について、胡椒チンキ、カンタリスチ
ンキ(動物生薬)、ニンニクエキス、セファランチンア
ルコール液等の生薬を使用した治療例は数多くある。Conventionally, there have been many treatments for alopecia areata using herbal medicines such as pepper tincture, cantharis tincture (animal herbal medicine), garlic extract, and cephalanthine alcohol solution.
しかしながら、何れも単味の生薬を用いてのものであり
、脱毛局所の生理機能を体質面から改善して発毛を促す
という根本的な治療薬を用いてのものは皆無に近かった
。However, all of them used simple herbal medicines, and almost none of them used fundamental therapeutic drugs that improved the physiological function of the hair loss area from a constitutional perspective and promoted hair growth.
本発明者等においても、単味の生薬の治療効果を確認す
べく、セファランチン濃度0.05%の30%エタノー
ル液(表1)、および、当薬の30%エタノール抽出液
についての臨床治験(表2)を試みた。In order to confirm the therapeutic effects of single herbal medicines, the present inventors conducted a clinical trial on a 30% ethanol solution with a cephalanthine concentration of 0.05% (Table 1) and a 30% ethanol extract of this drug (Table 1). Table 2) was attempted.
(以下、余白)
画表より明らかなように、単味の生薬による場合でも、
ある程度の治療効果が得られるものの、充分満足のいく
効果は得られないことが分かる。(Hereafter, blank space) As is clear from the chart, even when using simple herbal medicines,
It can be seen that although a certain degree of therapeutic effect can be obtained, a fully satisfactory effect cannot be obtained.
そこで、本発明者等は、下記に示すように、皮膚生理学
的に円形脱毛症における発毛および脱毛の要因を検討す
る一方、生薬学的に円形脱毛症の皮膚生理異常を改善す
る薬効を有する生薬育毛剤の探索を行なった。Therefore, as shown below, the present inventors examined the factors of hair growth and hair loss in alopecia areata from a skin physiological perspective, and also determined that there is a medicinal effect that improves the skin physiological abnormality of alopecia areata from a herbal pharmacological perspective. We searched for herbal hair growth agents.
(円形脱毛症における発毛および脱毛要因)毛髪が健全
に成長するためには、毛髪が皮膚にしっかり根づき、脱
けにくくなっていることが必要である。(Hair growth and hair loss factors in alopecia areata) In order for hair to grow healthy, it is necessary that the hair be firmly rooted in the skin and difficult to fall off.
そして、毛髪が皮膚にしっかりと根づくためには、
(11毛球の部分と毛のう壁が密着していること、およ
び、
(2)毛母と毛乳頭が固く結びついていることが必要で
ある。In order for hair to firmly take root in the skin, it is necessary that (11) the hair bulb and the hair follicle wall are in close contact, and (2) the hair matrix and dermal papilla are tightly connected. be.
上記(1)および(2)の要件が満たされるためには、
毛乳頭部の血液循環が順調に行なわれる必要があまた、
栄養神経の機能が、毛髪の発育を抑制したり、成長期毛
包に悪影響を与えたすせず正常に働くことも、発毛の重
要な要因である。In order to satisfy the requirements (1) and (2) above,
Blood circulation to the dermal papilla must also be maintained smoothly.
Another important factor in hair growth is that the trophic nerve functions normally without inhibiting hair growth or adversely affecting anagen hair follicles.
従って、上記発毛の要因のいずれかに、障害が起これば
、必然的に脱毛が生じる。Therefore, if any of the above hair growth factors are impaired, hair loss will inevitably occur.
発毛の障害因子および病理機転については種々の見解が
あるが、本発明者等は皮膚移植の際に起こる脱毛の発生
機序が、円形脱毛症の発生機序と似通った病理現象を示
すことに着目した。Although there are various opinions regarding the factors that inhibit hair growth and the pathological mechanism, the present inventors believe that the mechanism of hair loss that occurs during skin transplantation shows a pathological phenomenon similar to that of alopecia areata. We focused on
そこで、円形脱毛症の発生機序解明の一手段とすべく、
移植皮膚の発毛機転および皮膚生理の変化についての次
の如き動物実験を行った。Therefore, in order to elucidate the developmental mechanism of alopecia areata,
The following animal experiments were conducted to examine the mechanism of hair growth in transplanted skin and changes in skin physiology.
すなわち、兎の耳部に自家皮膚移植を行い、移植皮膚の
生着と、発毛が正常化するまでの皮膚組織の生理機能の
変化との関係を調べた。Specifically, autologous skin grafts were performed on rabbit ears, and the relationship between the engraftment of the grafted skin and changes in the physiological function of the skin tissue until hair growth normalized was investigated.
その結果、移植皮片は、皮膚移植後10〜14日前後で
生着したが、この時期においては皮下細網血管の新生が
高度で、リンパ球の細胞浸潤が認められた(以下、この
時期を「血管新生期」という)。As a result, the grafted skin took root around 10 to 14 days after skin transplantation, and at this time, there was a high degree of neogenesis of subcutaneous reticular vessels, and cell infiltration of lymphocytes was observed (hereinafter referred to as "this period"). (referred to as the ``angiogenesis phase'').
さらに、皮膚移植後30日前後経過すると、完全に皮膚
は生着し、紡織像も正常化し、リンパ球の浸潤も少なく
なり成長期毛の発毛が見られるようになった。Furthermore, about 30 days after the skin transplantation, the skin was completely engrafted, the texture pattern became normal, the infiltration of lymphocytes decreased, and hair growth in the anagen phase was observed.
上記二時期における皮膚の生理機能を、メチレンプラウ
消退時間およびQRZ吸収試験によって検査したところ
、メチレンプラウ消退時間もQRZ吸収吸収点管新生期
に短縮し、皮膚生着期にはともに正常値を示した。因み
に、皮膚移植によるかかる生理機能の変化の傾向は、人
体皮膚移植においても同様に認められた。When the physiological functions of the skin in the above two periods were examined by methylene plow resolution time and QRZ absorption test, the methylene plow resolution time also shortened during the QRZ absorption point tube formation stage, and both showed normal values during the skin engraftment stage. Ta. Incidentally, this tendency for changes in physiological functions due to skin transplantation was similarly observed in human skin transplantation.
上記、皮膚移植の際の血管新生期におけるメチレンプラ
ウ消退時間およびQRZ吸収吸収点縮は、血管新生期が
皮膚生理学的に新陳代謝の強い、生理機能が旺盛な時期
であることをを味する。The above-mentioned methylene plow disappearance time and QRZ absorption contraction in the angiogenesis period during skin transplantation demonstrate that the angiogenesis period is a period of strong skin metabolism and active physiological functions.
一方、円形脱毛症の患者の脱毛部と被髪頭部とについて
、メチレンプラウ消退時間とQRZ吸収吸収点測定した
結果、脱毛部においてはいずれも延長する傾向があった
。この事実から、円形脱毛症の患部の皮膚は、正常波s
e頭部の皮膚に比較して、皮膚生理機能が低下している
ことが分かった。On the other hand, as a result of measuring the methylene plow disappearance time and the QRZ absorption point on the bald area and the head of hair of patients with alopecia areata, there was a tendency for both to be longer in the bald area. From this fact, the skin in the affected area of alopecia areata has a normal wave s.
e It was found that the physiological function of the skin was lower than that of the skin on the head.
また、脱毛部における血液循環は著しく悪いことが分か
った。すなわち、脱毛部と健康部の皮膚温を比較した場
合、健康部の皮膚温の方が高く、発毛が進み病状が改善
するにつれて次第に脱毛部の皮膚温が上昇することが分
かった。これらの事実は、円形脱毛症局部における血行
阻害が、発毛機序に悪影響を与えていることを示すもの
である。It was also found that blood circulation in the hair removal area was significantly poor. That is, when comparing the skin temperature of the bald area and the healthy area, it was found that the skin temperature of the healthy area was higher, and as hair growth progressed and the medical condition improved, the skin temperature of the bald area gradually increased. These facts indicate that inhibition of blood circulation in the local area of alopecia areata has an adverse effect on the hair growth mechanism.
従って、円形脱毛症の治療において発毛を促す最善の策
は、脱毛症局部皮膚の生理機能の低下、とりわけ血液循
環と栄養状態を改善することであると言い得る。Therefore, it can be said that the best way to promote hair growth in the treatment of alopecia areata is to improve the decline in the physiological functions of the skin in the area affected by alopecia, especially the blood circulation and nutritional status.
本発明は、かかる知見に基づき、円形脱毛症に対して優
れた薬効を有する複合生薬を鋭意探索した結果なされた
ものであり、その目的とするところは、円形脱毛症に対
して優れた育毛効果を有する複合生薬育毛剤を提供する
にある。The present invention was made based on such knowledge and as a result of intensive search for complex herbal medicines that have excellent medicinal effects on alopecia areata.The present invention aims to provide excellent hair growth effects on alopecia areata. The object of the present invention is to provide a complex herbal medicine hair growth agent having the following properties.
上記目的を達成するための本発明に係る複合生薬育毛剤
は、人参、黄耆、附子、乾姜、桃仁、丹参、補骨脂、絹
様、紅花、当帰、川■および当薬を含有してなる。The complex herbal medicine hair growth agent according to the present invention to achieve the above object contains ginseng, Astragalus, Fuzi, Qianjiang, Taojin, Danshen, bone fat, silk, safflower, Dangki, Chuan, and this drug. It will be done.
なお、3薬100重量部に対して、人参、黄耆、附子、
乾委、桃仁、丹参、補骨脂、明徴、紅花、当帰および川
■をそれぞれ5〜40重量部の範囲内で含有するものが
好ましい。In addition, for 100 parts by weight of the three drugs, ginseng, Astragalus, Tsuzi,
It is preferable that the composition contains 5 to 40 parts by weight of each of dangan, peach nin, danshen, bone fat, mingjing, safflower, dangki, and chuan.
上記各生薬を、(1)補養薬、(2)温裏社寒薬および
(3〉活血ネ去璃理血薬能に分類して、その薬効を示す
。The above-mentioned herbal medicines are classified into (1) supplementary medicines, (2) warm medicines, and (3) medicinal effects of active blood, and their medicinal effects are shown.
(1)tii養薬
■人参
人参は全身的には滋養強壮作用があるが、この中に含有
されているビタミン類の中でB、およびB7が発毛促進
剤として働く、また、人参には抗ヒスタミン作用と関連
性のある薬効をもつことが分かっており、円型脱毛症の
自己免疫現象によって起こるアレルギー炎を抑制する。(1) Tii Health Medicine ■ Ginseng Ginseng has a nourishing and tonic effect on the whole body, but among the vitamins contained in it, B and B7 act as hair growth promoters. It is known to have medicinal effects related to antihistamine effects, and suppresses allergic inflammation caused by the autoimmune phenomenon of alopecia areata.
■黄耆
古くより、黄耆は癒家の生薬と言われ、皮膚病によく使
用される生薬である。体表の血液循環を改善し、皮膚の
栄養状態を高める。■ Astragalus Since ancient times, Astragalus has been said to be a healing herbal medicine, and is often used for skin diseases. Improves blood circulation on the body surface and enhances the nutritional status of the skin.
■補骨脂
皮膚を滋養し、血管を拡張する作用があるとともに、そ
のアルコール抽出液はメラニンを増生ずる作用がある。■Bone repair fat It has the effect of nourishing the skin and dilating blood vessels, and its alcoholic extract has the effect of increasing melanin.
■当帰 補血、行血作用があり、血液循環を改善する。■Go home It has blood supplementation and blood circulation effects, improving blood circulation.
ビタミンE欠乏症に拮抗する作用があり、黄耆と併用す
ると、局所の血液循環が改善される。It has an antagonizing effect on vitamin E deficiency, and when used in combination with Astragalus, local blood circulation is improved.
(2)温裏社寒薬
■附子
附子と乾姜との併用が血液循環を促進する。また、附子
には鑓痛および消炎作用がある。(2) Onurasha Cold Remedies■ Combination of Fuzi Fuzi and Qiangang promotes blood circulation. Fuzi also has anti-pain and anti-inflammatory properties.
■乾妾 血液循環を促進する。■Inui concubine Promote blood circulation.
■絹様 局所を刺戟して血液循環を促進する。■Kinu-sama Stimulates the local area and promotes blood circulation.
(3)活血ネを廚理血薬
■日参
血管を拡張し血液循環を促進し、局所の欝血や貧血状態
を改善する他、抗菌、填静および神経を安定させる作用
がある。(3) A drug that restores live blood. ■Das ginseng dilates blood vessels, promotes blood circulation, improves local congestion and anemia, and has antibacterial, sedative, and nerve stabilizing effects.
■桃に
欝血および凝血を改善し血液循環を促進する他、消炎お
よび解毒作用がある。紅花や用1との併用は血液循環を
改善する。■In addition to improving blood congestion and blood clots and promoting blood circulation, peaches have anti-inflammatory and detoxifying properties. Combination with safflower and yo 1 improves blood circulation.
■紅花
欝血や凝血をとる作用がある。特に、紅花油および紅花
酒は局所の内出血をとり、欝血を改善する作用がある。■Safflower has the effect of removing blood congestion and blood clots. In particular, safflower oil and safflower wine have the effect of removing local internal bleeding and improving blood congestion.
その他、情熱および消炎作用も有する。It also has passion and anti-inflammatory properties.
■」]情
血液循環を調整し、血管を拡張して栄養状態を良くする
。mqの水浸エキスはビタミン欠乏症に拮抗する作用が
ある。■''] Adjusts blood circulation, dilates blood vessels, and improves nutritional status. MQ water soak extract has an antagonizing effect on vitamin deficiencies.
次に、本発明に係る複合生薬育毛剤の製造方法について
説明する。Next, a method for producing the complex crude drug hair growth agent according to the present invention will be explained.
本発明に係る複合生薬育毛剤は、例えば、上記人参、黄
耆、附子、乾委、桃仁、丹参、補骨脂、絹様、紅花、当
帰および用1からなる複合生薬を水で煎じた後、それを
室温程度まで冷却した冷却煎液と、アルコール抽出して
得られた当薬の浸出液とを混合することにより得られる
。The composite herbal medicine hair growth agent according to the present invention is prepared by, for example, decocting a composite herbal medicine consisting of the above-mentioned ginseng, Astragalus, Zhuzi, Qiangan, Peach Ren, Danshen, Bone Fat, Silky, Safflower, Danggui, and Yo 1 with water. After that, it can be obtained by mixing the cooled decoction which has been cooled to about room temperature and the infusion of the drug obtained by alcohol extraction.
なお、上記当薬は、その中に含まれるスェルチアマリン
に発毛作用があることより複合生薬の一成分として配合
されるものである。This drug is formulated as a component of a complex herbal medicine because the swertiamarin contained therein has a hair growth effect.
上記アルコール抽出に用いるアルコールとしては、人体
に害を及ぼさないものであれば本発明においては特に限
定されず、例えばエチルアルコールを用いることができ
る。また、用いるアルコールの濃度は50%を越えない
ことが好ましく、20%を越えないことがより好ましい
、育毛剤中のアルコール濃度が50%を越えた場合は、
毛髪中の水分量の低下をきたし、その結果、毛髪の断裂
等が生じて、却って発毛が抑制される場合がある。The alcohol used in the alcohol extraction is not particularly limited in the present invention as long as it does not harm the human body, and for example, ethyl alcohol can be used. In addition, it is preferable that the concentration of alcohol used does not exceed 50%, and more preferably that it does not exceed 20%. If the alcohol concentration in the hair growth agent exceeds 50%,
This causes a decrease in the amount of water in the hair, resulting in hair breakage and the like, which may actually suppress hair growth.
なお、上記複合生薬の前液は、その冷却前にヒートロン
ペーパー、和紙等の濾過手段により濾別したものを用い
ることが好ましい、上記アルコールの浸出液についても
、同様である。In addition, it is preferable to use the preliquid of the composite herbal medicine that has been filtered by a filtering means such as Heatron paper or Japanese paper before cooling. The same applies to the alcoholic infusion solution.
また、得られた複合生薬育毛剤をさらに遠心分離機など
にかけて易沈降性の物質を除去すれば、長期間保存して
も沈澱物の生じない商品価値の高い複合生薬育毛剤を得
ることが可能になる。In addition, if the obtained composite herbal hair growth agent is further subjected to a centrifuge to remove easily sedimentable substances, it is possible to obtain a complex herbal hair growth agent with high commercial value that does not produce sediment even after long-term storage. become.
本発明に係る複合生薬育毛剤は、脱毛の程度に応じて適
宜の頻度で塗布することができるが、通常、−日朝タ二
回、脱毛局所にマツサージを行いながら塗布する等の方
法を用いることができる。The composite crude drug hair growth agent according to the present invention can be applied at an appropriate frequency depending on the degree of hair loss, but usually, it is applied to the hair loss area twice in the morning and twice while performing a pine surge. I can do it.
なお、三日に一度は、洗髪を行い、その後に塗布するこ
とが好ましい。In addition, it is preferable to wash your hair once every three days and then apply the product.
以下、本発明を実施例に基づいてさらに詳細に説明する
が、本発明は下記実施例により何ら限定されるものでは
なく、その要旨を変更しない範囲において適宜変更実施
可能なものである。Hereinafter, the present invention will be explained in more detail based on Examples, but the present invention is not limited to the following Examples in any way, and can be modified as appropriate without changing the gist thereof.
(A)複合生薬育毛剤の調製
根の部分を切除した9薬30グラムを、5日間室温で7
0%濃度のエチルアルコール500rnlに浸漬してア
ルコール抽出した後、ヒートロンペーパーを用いて、当
薬の浸出液400−を濾別した。(A) Preparation of complex herbal drug hair growth agent 30 grams of 9 drugs with the roots removed were kept at room temperature for 5 days.
After alcohol extraction by immersion in 500 rnl of 0% ethyl alcohol, the exudate of the drug was filtered using Heatron paper.
一方、人参6グラム、黄耆6グラム、附子6グラム、乾
姜6グラム、桃仁3グラム、丹参6グラム、補骨脂3グ
ラム、胡4N10グラム、紅花6グラム、当帰6グラム
、Jll % 3グラムからなる生薬を水1400mで
2時間前じた後、ヒートロンペーパーを用いて、複合生
薬の前液約1000−を濾別し、濾液を室温まで放冷し
た。On the other hand, 6 grams of ginseng, 6 grams of Astragalus, 6 grams of Fuzi, 6 grams of dried ginger, 3 grams of peach kernels, 6 grams of Danseng, 3 grams of bone fat, 10 grams of Hu 4N, 6 grams of safflower, 6 grams of Dangki, Jll% 3 After pre-preparing the crude drug consisting of 1,400 g of water for 2 hours in 1,400 m of water, about 1,000 g of the preliminary solution of the composite crude drug was filtered using Heatron paper, and the filtrate was allowed to cool to room temperature.
次いで、上記3薬の浸出液約400mと複合生薬の冷却
烈液約1000aeとを混合して、アルコール濃度20
%程度のトニックタイプの複合生薬育毛剤1400dを
1F11また。Next, about 400 m of the infusion liquid of the above three drugs and about 1000 ae of the cooled liquid of the composite herbal medicine were mixed to give an alcohol concentration of 20.
% of tonic type complex herbal medicine hair growth agent 1400d at 1F11.
得られた複合生薬育毛剤を5℃の温度に1週間保持して
易沈降性物質を自然沈澱させ、次いで、その上澄液約1
200Idを遠心分離機(回転数:3000rpm)に
30分間かけた後、濾過して易沈降性物質が実質上完全
に除かれた複合生薬青毛剤約1200dを調製した。The obtained composite herbal hair growth agent was kept at a temperature of 5°C for one week to allow the easily sedimented substances to precipitate naturally, and then the supernatant liquid was mixed with approx.
200Id was placed in a centrifuge (rotation speed: 3000 rpm) for 30 minutes, and then filtered to prepare approximately 1200d of a complex herbal medicine from which easily sedimentable substances were substantially completely removed.
(B)臨床治験
上記(A)で調製した複合生薬育毛剤を用いて、総症例
数49名について臨床治験を行った。(B) Clinical trial A clinical trial was conducted on a total of 49 patients using the composite herbal hair growth agent prepared in (A) above.
育毛剤は一日朝タ二回、脱毛局所にマツサージを行いな
がら塗布した。三日に一度は、洗髪し、その後に塗布し
た。The hair restorer was applied twice a day, once in the morning, to the hair loss area while performing a pine surge. I applied it once every three days after washing my hair.
円形脱毛症の臨床型を、通常型(この型を単発性のもの
と多発性のものとに分類した)、全類型および汎発型に
分類し、冬型側に、著効、有効および無効の三段階に分
類し、各分類別に効果の判定を行った。The clinical types of alopecia areata are classified into normal type (this type is classified into single type and multi-type type), general type, and generalized type. It was classified into three levels, and the effects were evaluated for each category.
結果を表3に示す、なお、同表中、著効とは、硬毛の発
生をみることができ、地肌が見えない程度に完治したも
のをいう、有効とは、硬毛の発生をみることはできたが
未だ地肌が見える程度の改善に止まるものをいう、また
、無効とは、自覚的他覚的に改善を見たものの4毛の発
生程度であるもの、硬毛の新生がみうけられるが未だな
お脱毛の続くもの、および、発毛が全くみうけられない
ものをいう。The results are shown in Table 3. In the same table, "remarkable response" means that the growth of terminal hair can be seen and the skin has completely healed to the extent that the scalp cannot be seen. "Effective" means that the development of terminal hair can be seen. The term "ineffective" refers to cases in which improvement was achieved, but the improvement was still only to the extent that the scalp was visible. Also, "ineffective" refers to cases in which improvement was achieved subjectively and objectively but only the appearance of 4 hairs, or new growth of terminal hairs was observed. However, this refers to those who still experience hair loss, and those who do not see any hair growth.
(以下、余白)
表3
(C)臨床治験結果
表3より明らかなように、通常型(単発性)円形脱毛症
14例中、著効12例、有効2例で100%の有効率を
示し、著効例のみの有効率でも86%を示す、治療期間
は効果の早い症例では1ケ月、遅い症例では5ケ月間の
治療期間であった。(The following is a blank space) Table 3 (C) Clinical trial results As is clear from Table 3, out of 14 cases of conventional (single) alopecia areata, 12 cases showed excellent response and 2 cases showed effective response, showing a 100% efficacy rate. The efficacy rate was 86% for only those with a good response, and the treatment period was one month for those with a quick response and five months for a slow response.
平均治療期間は2ケ月程度であった。The average treatment period was about 2 months.
通常型(多発性)円形脱毛症17例では、著効11例、
有効6例で、100%の有効率を示し、著効例のみの有
効率は67.5%を示す、治療期間は効果の早い症例で
は3ケ月、遅い症例では1ケ年近くの治療期間を要した
。平均治療期間は7ケ月程度であった。In 17 cases of normal type (multifocal) alopecia areata, 11 cases showed excellent response;
The efficacy rate was 100% in 6 cases, and the efficacy rate in only excellent cases was 67.5%.The treatment period was 3 months in cases where the effect was early, and nearly 1 year in cases where the effect was slow. It took. The average treatment period was approximately 7 months.
会頭型円形脱毛症9例では、著効4例、有効4例、無効
1例で、88%の有効率を示し、著効例のみの有効率は
44%である。平均治療期間は7ケ月半程度であった。In 9 cases of alopecia areata cephalus, there were 4 cases of excellent response, 4 cases of good response, and 1 case of poor response, showing an efficacy rate of 88%, and the efficacy rate of only excellent response cases was 44%. The average treatment period was about seven and a half months.
汎発型円形脱毛症9例では、著効4例、有効2例、無効
3例で、66%の有効率を示し、著効のみの有効率は4
4%で、平均治療期間は10ケ月程度であった。In 9 cases of generalized alopecia areata, there were 4 cases of excellent response, 2 cases of good response, and 3 cases of no response, showing an efficacy rate of 66%, and the efficacy rate for only severe response was 4.
4%, and the average treatment period was about 10 months.
円形脱毛症に対する生薬育毛剤の効果は通常型に最も長
幼であり、しかも短期間の治療で済むことが分かる。It can be seen that the effects of herbal hair restorers on alopecia areata are the longest compared to the normal type, and that only a short period of treatment is required.
また、性別については、男性より女性に有効率が高いこ
とが分かる。Regarding gender, it can be seen that the effectiveness rate is higher for women than for men.
以上、詳細に説明したように、本発明に係る複合生薬育
毛剤は、発毛時の生理機能の変化と生薬の薬効との関係
についての臨床的な裏付けをもとに調製されたものであ
るため、皮膚生理機能を根本的に改善することにより、
円形脱毛症に対して優れた育毛効果を有する。As explained above in detail, the complex crude drug hair growth agent according to the present invention was prepared based on clinical evidence regarding the relationship between changes in physiological function during hair growth and the medicinal efficacy of crude drugs. Therefore, by fundamentally improving skin physiological functions,
It has an excellent hair growth effect on alopecia areata.
以上の如く、本発明は優れた特有の効果を奏する。As described above, the present invention has excellent and unique effects.
Claims (1)
椒、紅花、当帰、川■および当薬を含有することを特徴
とする複合生薬育毛剤。 2、当薬100重量部に対して、人参、黄耆、附子、乾
姜、桃仁、丹参、補骨脂、胡椒、紅花、当帰および川■
を各々5〜40重量部の範囲内で含有する請求項1記載
の複合生薬育毛剤。 3、人参、黄耆、附子、乾姜、桃仁、丹参、補骨脂、胡
椒、紅花、当帰および川■を含有する複合生薬の冷却煎
液と当薬のアルコール抽出液とを混合してなる請求項1
または2記載の複合生薬育毛剤。 4、請求項1〜3のいずれかに記載の複合生薬育毛剤か
ら易沈降性物質を除去してなる複合生薬育毛剤。[Scope of Claims] 1. A complex herbal medicine hair growth agent characterized by containing ginseng, Astragalus, Fuzi, Qianjiang, Taojin, Danshen, bone fat, pepper, safflower, Dangki, Chuan, and this drug. . 2. For 100 parts by weight of this drug, ginseng, Astragalus, Zhuzi, Qianjiang, Peach Ren, Danshen, bone fat, pepper, safflower, Dangki and Kawa■
The complex hair growth agent according to claim 1, containing 5 to 40 parts by weight of each of the following. 3. Mix the cooled decoction of a composite herbal medicine containing ginseng, Astragalus, Zhuzi, dried ginger, peach kernel, Danshen, bone fat, pepper, safflower, Danggui and Chuan ■ with the alcoholic extract of this medicine. Claim 1
or the complex herbal medicine hair growth agent described in 2. 4. A composite herbal medicine hair growth agent obtained by removing easily sedimentable substances from the composite herbal medicine hair growth agent according to any one of claims 1 to 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1202128A JPH0366606A (en) | 1989-08-03 | 1989-08-03 | Hair tonic of compound crude drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1202128A JPH0366606A (en) | 1989-08-03 | 1989-08-03 | Hair tonic of compound crude drug |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0366606A true JPH0366606A (en) | 1991-03-22 |
Family
ID=16452430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1202128A Pending JPH0366606A (en) | 1989-08-03 | 1989-08-03 | Hair tonic of compound crude drug |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0366606A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10265350A (en) * | 1997-03-26 | 1998-10-06 | Shiseido Co Ltd | Hair tonic |
JPH10265349A (en) * | 1997-03-26 | 1998-10-06 | Shiseido Co Ltd | Hair tonic |
JP2007320970A (en) * | 2007-09-10 | 2007-12-13 | Naris Cosmetics Co Ltd | Cosmetic |
WO2008111271A1 (en) * | 2007-03-15 | 2008-09-18 | Kaigen Co., Ltd. | Oral composition for nourishing the hair and stimulating hair growth |
-
1989
- 1989-08-03 JP JP1202128A patent/JPH0366606A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10265350A (en) * | 1997-03-26 | 1998-10-06 | Shiseido Co Ltd | Hair tonic |
JPH10265349A (en) * | 1997-03-26 | 1998-10-06 | Shiseido Co Ltd | Hair tonic |
WO2008111271A1 (en) * | 2007-03-15 | 2008-09-18 | Kaigen Co., Ltd. | Oral composition for nourishing the hair and stimulating hair growth |
JP2007320970A (en) * | 2007-09-10 | 2007-12-13 | Naris Cosmetics Co Ltd | Cosmetic |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100761660B1 (en) | A composition for promoting hair growth | |
WO2011093656A2 (en) | Shampoo containing a composition for hair loss prevention and hair growth stimulation using herb medicines | |
JP5646117B2 (en) | Hair growth promoter and production method | |
US4849214A (en) | Oil based scalp treatment composition | |
CN112870333A (en) | Composition and preparation for improving alopecia and promoting hair growth of human, and preparation method and application thereof | |
CN107412709B (en) | Chinese herbal medicine composition with alopecia stopping and hair growth effects and preparation method thereof | |
KR20090012565A (en) | Compositions for preventing hair loss or stimulating hair growth containing natural extract | |
CN112826900B (en) | Traditional Chinese medicine composition for treating seborrheic alopecia and pharmaceutical preparation thereof | |
CN106994148A (en) | A kind of anti acne of traditional Chinese medicine preparation | |
JPH0366606A (en) | Hair tonic of compound crude drug | |
JP2648618B2 (en) | Wakan hair restorer | |
CN115813833A (en) | Bacteriostatic anti-inflammatory hair-growing essence and preparation method thereof | |
CN106177192B (en) | Bi-component compound medicine for treating head oil and dandruff and preparation method thereof | |
JPH0640856A (en) | Agent for promoting growth and restoration of hair and its production | |
KR101237635B1 (en) | Composition preventing lose of hair and promoting growth of hair and the product using thereof | |
CN111939191B (en) | Composition for promoting angiogenesis around hair follicle and/or promoting hair growth and application | |
KR100603122B1 (en) | Compositions of herbal extracts and pharmaceutical compositions for preventing loss of hair and promoting growth of hair | |
KR20090022224A (en) | Cosmetic composition for scalp protection and trichogenousness | |
KR20140018699A (en) | Method for manufacturing hair growth promotion/hair loss prevention shampoo. | |
CN112076268A (en) | Traditional Chinese medicine lotion for preventing and treating alopecia and blackening hair, preparation method and application | |
CN101317911A (en) | Chinese medicinal herb formula for phalacrosis prevention and hair generation, and preparation method thereof | |
JPH01213215A (en) | Hair tonic | |
CN113768803B (en) | Composition of anti-hair loss and anti-dandruff spray and preparation method thereof | |
WO1998006412A1 (en) | A medicine of external use for treating seborrheic baldness with high efficacy and low side effect and preparation thereof | |
KR20100111640A (en) | Manufacturing method of cosmetic composition for trichogenousness or anti-alopecia |